Dr. Hai Li
Dr. Hai Li is a Senior Scientist specializing in cellular and molecular biology, focusing on gene editing, engineered immune cells, and other mammalian cell lines for drug development and cancer immunotherapy. Dr. Li holds a Ph.D. in Cellular and Molecular Biology from Université Claude Bernard Lyon 1. Dr. Li engineered allogeneic T cells at Sana […]
Dr. Kayla Bean
Kayla completed her B.S. at University of Tennessee Knoxville in Microbiology and attended Georgia State University for MS and PhD degrees in Applied and Environmental Microbiology. She did her postdoctoral work in Cell Line Engineering at Elanco before joining AGC Biologics in 2021. She is currently based in Bothell, WA as the AGC Biologics R&D […]
Dr. Michelle Sabourin
Dr. Michelle Sabourin is a cell and molecular biologist with over 15 years of industry experience in cell line development (CLD). Prior to Cytiva/GE Healthcare, she worked in R&D for Gibco where she developed products for the CLD space. In her current role, Michelle is responsible for CLD projects as part of Cytiva’s Cell Culture […]
Rosita Paleckyte
Rosita Paleckyte is a junior scientist in the Analytical development department in Polpharma Biologics, the Netherlands. Although her educational background focused on molecular biology, she started her career as a research associate in the AD department in Polpharma Biologics. Initially focused mainly on capillary electrophoresis methods, she quickly moved on towards assessment and implementation of […]
Dr. Piotr Mamczur
Dr. Piotr Mamczur is a biotechnology and biopharmaceutical expert with nearly 20 years of experience in protein science, specializing in the production of functional proteins and the development of upstream and downstream processes for antibodies. He is currently a Senior Scientist at Selvita S.A., focusing on antibody drug discovery, with a particular emphasis on antibodies […]
Anand Khristi
Anand Khristi is an accomplished Biopharmaceutical Formulation Scientist at Intas Accord Biopharmaceutical Pvt. Ltd., with deep expertise in the development and commercialization of complex protein-based therapeutics, including high concentration monoclonal antibodies, fusion proteins, and drug conjugates. Anand is adept at driving end-to-end formulation strategies, from conceptualization to large-scale production, with a specialization in lyophilization and […]
Dr. Séverine Fagète
Séverine is the Vice President of Mammalian Cell Line Development (CLD) at KBI Biopharma’s Geneva Facility. Prior to the operational consolidation with KBI, Séverine held multiple leadership roles with escalating responsibilities at Selexis. She brings nearly two decades of experience in the pharmaceutical industry, and deep expertise in early drug discovery, antibody engineering (bispecifics), stable […]
Dr. Rebecca Boohaker
Dr. Boohaker is the study director for the oncology department. She designs, oversees, executes and interprets all cancer-related in vivo studies to evaluate potential cancer treatments, including cancer-fighting viruses and other agents that might help combat the disease. Trained primarily as a molecular biologist, Dr. Boohaker’s graduate work at the University of Central Florida resulted […]
Dr. Lena Tholen
Dr. Lena Tholen holds a Diploma in Biotechnology from the Technical University of Berlin (2013) and gained research experience at KTH, focusing on high cell density perfusion processes with CHO cells. She earned a PhD (2014-2017) for her work on CHO cell-based cell-free systems in collaboration with Fraunhofer IZ-BB. Since 2019, she has worked as […]
Dr. Anne Kathrin Barthel
More information coming soon
